UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse P-acc, USD/ LU0069152568 /
| NAV2024-05-14 | Chg.+6.5800 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 696.0000USD | +0.95% | reinvestment | Equity | UBS Fund M. (LU) ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 2024-05-17 | Public WebStation Live Factsheet | 2024 | English | - |
| 2024-04-24 | PRIIP Key Information Document | 2024 | German | 99.45 KB |
| 2024-04-20 | Prospectus | 2024 | English | 2,030.67 KB |
| 2024-04-20 | Prospectus | 2024 | German | 2,093.54 KB |
| 2023-11-30 | Account statment | 2023 | English | 2,674.34 KB |
| 2023-11-30 | Account statment | 2023 | German | 1,415.90 KB |
| 2023-08-24 | PRIIP Key Information Document | 2023 | English | 101.70 KB |
| 2023-05-31 | Semi-annual report | 2023 | English | 1,223.68 KB |
| 2023-05-31 | Semi-annual report | 2023 | German | 1,239.69 KB |
| 2022-11-10 | Key Investor Information | 2022 | German | 58.90 KB |
| 2012-01-27 | Key Investor Information | 2012 | English | 120.01 KB |
